Monopar Therapeutics Inc.

Monopar Therapeutics Inc. financial statements

Monopar Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 010-K
Net income−USD 13.72M10-K
Cash and equivalentsUSD 61.83M10-Q
Total debtUSD 154.92KEODHD

Monopar Therapeutics Inc. financials on 6ix · Monopar Therapeutics Inc. on 6ix